美国AI医疗临床对话纪录平台Abridge近日宣布获得1.5亿美元的C轮融资，投后估值达到8.5亿美元。此次融资由Lightspeed和Redpoint Ventures共同领投，Mass General Brigham AIDIF、Kaiser Permanente Ventures以及Bessemer Venture Partners和CVS Health Ventures等现有投资者跟投。
Abridge利用人工智能技术帮助医生将患者检查的录音自动转换为医疗记录，极大提升了医疗效率和准确性。到目前为止，Abridge已经与10000多名临床医生签订了使用其软件的合同，显示出市场对AI医疗解决方案的强劲需求。
此次融资的成功，不仅体现了投资者对Abridge技术实力和市场潜力的认可，也反映了AI技术在医疗领域的广泛应用前景。随着医疗数据的不断增长和患者对医疗服务效率的需求不断提高，AI医疗有望成为推动医疗行业变革的重要力量。
英文标题：Abridge Raises $150 Million in Series C Funding, Valuation Reaches $850 Million
英文关键词：AI Healthcare, Funding Round, Series C
英文新闻内容：
Abridge, an AI-powered clinical conversation recording platform, has recently announced the closure of a $150 million Series C funding round. The company’s valuation has soared to $850 million post-investment. The round was jointly led by Lightspeed and Redpoint Ventures, with participation from existing investors including Mass General Brigham AIDIF, Kaiser Permanente Ventures, Bessemer Venture Partners, and CVS Health Ventures.
Abridge uses AI to automatically transcribe patient check-up recordings into medical records, significantly enhancing efficiency and accuracy in healthcare. To date, the company has signed contracts with over 10,000 clinical practitioners, underscoring a strong market demand for AI solutions in healthcare.
The successful funding round not only reflects the investor’s recognition of Abridge’s technological capabilities and market potential but also indicates a bright future for AI applications in the healthcare industry. As medical data continues to grow and patients demand higher service efficiency, AI healthcare is expected to become a major driving force for transformation in the medical sector.
【来源】https://www.forbes.com/sites/katiejennings/2024/02/23/abridge-raises-150-million-to-make-ai-medical-scribes-even-smarter/
Views: 1